Recent content by Business of Cannabis

The US cannabis rescheduling project, which has been stuck in limbo since being ‘temporarily’ shelved six months ago, is now facing another existential threat from the government’s wide reaching budget. On Tuesday (July 15), the House Appropriations Committee voted (9-6) to pass the ‘Fiscal...

It was the goal of the previous German coalition government to protect the health of patients and consumers by legalising cannabis, ensuring better protection of minors and diversion from black market trade thanks to legal alternatives. Unfortunately, many of the project’s plans could not be...

Two new bipartisan bills to legalise adult-use cannabis have been introduce by lawmakers in Pennsylvania, reiginiting hopes for advocates and potentially making the state the 25th in the US to push through such legislation. The latest House proposal, unveiled on Monday, is co-sponsored by...

Outrage and rancor swelled Friday after federal immigration raids at two state-licensed cannabis cultivation sites in Southern California operated by publicly traded Glass House Brands. The situation quickly drew national attention, including from Gov. Gavin Newsom, who criticized President...

The cannabis telemedicine industry, namely the flood of online healthcare businesses offering prescriptions virtually across global medical cannabis markets, has provided the greatest boom to the industry since the ‘green rush’ of 2018 in recent years. Now, however, governments and medical...

Grow Group, one of the UK’s leading medical cannabis distributors now supplying over 10,000 patients internationally, announced a major strategic shift to bring control of its operations entirely in house. The UK’s medical cannabis market, the fabric of which Grow is deeply woven into, is...

Efforts to close the so-called ‘hemp loophole’ in the US, which would have banned the sale of hemp-derived products containing any detectable amount of THC, could be postponed by a year, giving operators room to adapt their operations. Amid the continued scramble to push through the US’s giant...

UK Medical cannabis operator Grow Group has announced a significant expansion of its full-service UK medical cannabis distribution platform, as it launches the newly rebranded Grow Group UK. As part of this evolution, Grow Group UK has concluded its long-standing joint venture with IPS Pharma...

The frozen US cannabis rescheduling process appears to be stuck in limbo for the foreseeable future, as the Drug Enforcement Administration’s (DEA’s) new management confirmed the process ‘remains pending’. In a joint report to DEA Administrative Law Judge (ALJ) John Mulrooney earlier this week...

The exodus of listed cannabis companies from the public markets, particularly in the UK, is continuing at pace as yet another medical cannabis operator has announced plans to delist. It comes at a critical time not just for the UK’s cannabis sector, but its economy at large. Against the...

Since the partial legalisation of cannabis in Germany, the industry has grown considerably, particularly in the medical sector. While it was previously quite difficult for patients to obtain the desired medicine via an open-minded doctor using a BtM prescription, a normal prescription is now...

In this special edition of the Business of Cannabis Podcast, we go From Anecdote to Evidence with Dr Anne Katrin Schlag, Head of Research at Drug Science, and Graham Woodward, Chief Operating Officer at Releaf. Together, they explore how the UK can move from anecdotal patient stories to robust...

Over the past eight months, Business of Cannabis, Cannabis Health, leafie and CannaReporter have conducted a wide-ranging investigation into Dr Green Digital Key — a high-profile blockchain project positioning itself as a game-changer in global cannabis access. Backed and vocally promoted by a...

Doctors at the US Department of Veterans Affairs (VA) may soon be allowed to recommend medical cannabis to patients, following the passage of a landmark House spending bill that seeks to align federal veterans’ care with state-level cannabis laws. The measure, part of the fiscal year 2026...

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the...